Global Novel Drug Delivery Systems (NDDS) Market: Global Market Size, Industry Share, Approaches and Forecast 2017-2025, Acute Market ReportsGlobal Novel Drug Delivery Systems (NDDS) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 - 2025, the Novel Drug Delivery Systems (NDDS) market was valued at USD 169.8 Bn and is expected to reach USD 246.2 Bn by 2025, expanding at a CAGR of 2.7% from 2017 to 2025.
The novel drug delivery system (NDDS) provides a therapeutic amount of drug to the specific site in the body to accomplish promptly and then maintain the desired drug concentration.
Browse Full Report: http://www.acutemarketreports.com/report/novel-drug-delivery-systems-ndds-market
The drug- delivery system should deliver drug at a rate control by the necessarily of the body over a specified term of treatment. Market experts suggest that, There is a continuous growth in the market of drug delivery systems and will continue to grow at an impressive rate in future also.
The novel drug delivery technologies enable to formulate the novel drug delivery devices by incorporating the drug molecules into new delivery systems, thus providing numerous therapeutic and commercial advantages. It was observed that NDDS market was segmented on the basis of route of administration, type of carrier and geographical region. In route of administration segment, injectable drug delivery system was observed as the largest market in 2015 followed by oral drug delivery system. Injectable drug delivery system comprises of several benefits over other dosage forms in cases such as unconsciousness, nausea, in emergency clinical episodes. The injectable administration route is the most common and efficient for delivery of active drug substances with poor bio-availability and the drugs with a narrow therapeutic index. On the basis of type of carrier, liposomes and microspheres collectively attribute the largest share in the market in terms of revenue (USD). The key factors assisting the growth of liposomes market are such as, biologically active materials encapsulated within liposomes are protected to varying extent from immediate dilution or degradation which assists drug carrier systems for the transport of drugs and other bioactive capsules to disease-affected organs
Market Competition Assessment:
The key players involved in the novel drug delivery systems (NDDS) market are 3M Company, Abbott Laboratories Ltd., Amgen Inc., AstraZeneca Plc, Bausch & Lomb, Baxter International Inc., Bayer AG, Boehringer Ingelheim, Boston Scientific, Bristolmyers Squibb, Celgene Corporation, Cephalon, Inc., Genentech Inc., Genzyme Corporation, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi SA, and Teva Pharmaceutical Industries Ltd.
Key Market Movements:
• North America is expected to lead the global novel drug delivery systems market due to high disposable income, increasing research and development activities associated with development of drug delivery systems, high adoption rate of novel technologies and supportive reimbursement policies.
• Projected market entry of several products and technologies during 2016 to 2022 in global novel drug delivery systems market are expected to provide an exceptional growth to the market
• Novel drug delivery systems market is expected to intensify the market competition, ignition of price wars, and drive emphasis towards geographical expansion and penetration strategies to sustain in the competition
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology
Chapter 2 Executive Summary
2.1 Novel Drug Delivery Systems Market, by Route of Administration Type, 2017 - 2025 (USD Million)
2.2 Novel Drug Delivery Systems Market Share, by Carrier Type, 2025 (Value %)
2.3 Novel Drug Delivery Systems Market Share, by Geography, 2025 (Value %)
Chapter 3 Novel Drug Delivery Systems: Market Dynamics and Outlook
3.1 Introduction and Key Statistics
3.2 Novel Drug Delivery System: Current and Future Trends
3.3 Market Inclination Insights
3.4 Major Commercial Events
3.5 Market Dynamics
3.6 Porter's Five Forces Model
3.7 Attractive Investment Proposition
3.8 Market Positioning of Key Manufacturers.......
Browse Full Report: http://www.acutemarketreports.com/report/novel-drug-delivery-systems-ndds-market
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.
Company Name: Acute Market Reports
Contact Person: Chris Paul
Phone: Toll Free US/Canada: +1-855-455-8662
Address:105 N 1st ST #429, SAN JOSE, CA 95103
Country: United States
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Novel Drug Delivery Systems (NDDS) Market: Global Market Size, Industry Share, Approaches and Forecast 2017-2025, Acute Market Reports here
News-ID: 919533 • Views: 130
More Releases from Acute Market Reports
Bronchitis Treatment Market Size, Share, Growth Is Expected To Reach US$ 4,606.3 …
According to the latest report published by Credence Research, Inc. “Bronchitis Treatment Market By Type Of Drug Class (Antitussives/ Expectorants, Bronchodilators, Beta-Adrenergic Agonist, Systemic Corticosteroids, Inhaled Corticosteroids, Phosphodiesterase-4 Inhibitors, Analgesics, Antibiotics) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global Bronchitis Treatment market was valued at USD 3,345.8 Mn in 2017, and is expected to reach USD 4,606.3 Mn by 2026, expanding at a CAGR of 4.9% from
5.2% CAGR to take Cervical Cancer Treatment Market to USD 10.6 bn by 2025
The latest market report published by Credence Research, Inc. “Global Cervical Cancer Treatment Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global cervical cancer treatment market is expected to expand at a CAGR of 5.2% from 2018 to 2026. Market Insights According to the latest research citings of World Health Organization (WHO) in 2018, approximately 570,000 new cases if cervical cancer were reported which eventually represents 6.6% of all
Floating Solar Panels Market: Global Industry Share, Market Trends and Forecast …
According to a new market report published by Credence Research Global Floating Solar Panels Market- Growth, Future Prospects & Competitive Analysis, 2016 - 2023, the Global Floating Solar Panels Market is expected to reach US$ 842.0 Mn by 2023, expanding at a CAGR of 65.1% during the forecast period 2016 to 2023. Browse the full Global Floating Solar Panels Market by Product Type, Location and Geography - Growth, Future Prospects &
Molecular Diagnostics Market: Global Market Share, Size, Industry Approaches, St …
Molecular Diagnostics Market - Market Growth, Future Prospects, Competitive Analysis, 2017 - 2025, the global molecular diagnostics market was valued at US$ 6,077.9 Mn in 2016, and is expected to reach US$ 12,358.6 Mn by 2025 expanding at a CAGR of 7.8 % from 2017 to 2025. View Full Report with TOC @ http://www.acutemarketreports.com/report/molecular-diagnostics-market Market Insights Molecular diagnostics has undergone tremendous technological advancement due to the growing need for personalized medication, rapid diagnosis
More Releases for Drug
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning